Lipid metabolism remodeling the immunological landscape of hepatocellular carcinoma: From mechanisms to therapeutics.
Hepatocellular carcinoma (HCC) remains a major global malignancy with high incidence and poor survival rates. Etiology-driven metabolic-immune interactions have emerged as a unifying framework for deciphering hepatocarcinogenesis. Hepatitis B virus (HBV) and metabolic dysfunction-associated steatotic liver disease (MAS...